Literature DB >> 20157716

Radiochemotherapy versus radiotherapy in locally advanced cervical cancer: a meta-analysis.

Na Wang1, Quan-Lin Guan, Kai Wang, Xin Zhou, Chen Gao, Han-Teng Yang, Tian-Gen Ni.   

Abstract

OBJECTIVE: The objectives of this review are to compare the effectiveness and safety of radiochemotherapy (RTCT) with radiotherapy (RT) alone in locally advanced cervical cancer (LACC). DATA SOURCES: We comprehensively searched the Cochrane library, Medline, EMBASE, Chinese biomedicine literature database, Chinese scientific full-text database and Chinese journal full-text database for relevant articles. The computer search was supplemented with a manual search of reference lists for all available review articles. Also reference lists of the included studies were reviewed.
RESULTS: We included 18 randomized trials involving 3,517 patients. Meta-analysis results are as follows: the response rate, 3 and 5-year survival rates were significantly better in patients in the RTCT group than in RT group. As adverse effects, limited evidence suggests that there was no significant difference between the two groups with regard to rectitis, cystitis, nausea and vomiting. But RTCT group has higher incidence rates than RT group in gastrointestinal, myelosuppression and leucopenia.
CONCLUSION: The combination of radiotherapy and chemotherapy was more effective for LACC than radiotherapy alone. There was no significant difference between the RTCT regimen group and RT regimen group with regard to adverse effects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20157716     DOI: 10.1007/s00404-010-1385-5

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  5 in total

1.  Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy.

Authors:  Matthias W Beckmann; Frederik A Stübs; Martin C Koch; Peter Mallmann; Christian Dannecker; Anna Dietl; Anna Sevnina; Franziska Mergel; Laura Lotz; Carolin C Hack; Anne Ehret; Daniel Gantert; Franca Martignoni; Jan-Philipp Cieslik; Jan Menke; Olaf Ortmann; Carmen Stromberger; Karin Oechsle; Beate Hornemann; Friederike Mumm; Christoph Grimm; Alina Sturdza; Edward Wight; Kristina Loessl; Michael Golatta; Volker Hagen; Timm Dauelsberg; Ingo Diel; Karsten Münstedt; Eberhard Merz; Dirk Vordermark; Katja Lindel; Christian Wittekind; Volkmar Küppers; Ralph Lellé; Klaus Neis; Henrik Griesser; Birgit Pöschel; Manfred Steiner; Ulrich Freitag; Tobias Gilster; Alexander Schmittel; Michael Friedrich; Heidemarie Haase; Marion Gebhardt; Ludwig Kiesel; Michael Reinhardt; Michael Kreißl; Marianne Kloke; Lars-Christian Horn; Regina Wiedemann; Simone Marnitz; Anne Letsch; Isabella Zraik; Bernhard Mangold; Jochen Möckel; Céline Alt; Pauline Wimberger; Peter Hillemanns; Kerstin Paradies; Alexander Mustea; Dominik Denschlag; Ulla Henscher; Reina Tholen; Simone Wesselmann; Tanja Fehm
Journal:  Geburtshilfe Frauenheilkd       Date:  2022-02-11       Impact factor: 2.915

2.  LC-MS/MS assay for the quantitation of the ribonucleotide reductase inhibitor triapine in human plasma.

Authors:  Julia Matsumoto; Brian F Kiesel; Robert A Parise; Jianxia Guo; Sarah Taylor; Marilyn Huang; Julie L Eiseman; S Percy Ivy; Charles Kunos; Edward Chu; Jan H Beumer
Journal:  J Pharm Biomed Anal       Date:  2017-08-31       Impact factor: 3.935

3.  The cervix cancer research network: increasing access to cancer clinical trials in low- and middle-income countries.

Authors:  Gita Suneja; Monica Bacon; William Small; Sang Y Ryu; Henry C Kitchener; David K Gaffney
Journal:  Front Oncol       Date:  2015-02-19       Impact factor: 6.244

4.  Survival Comparison Between Squamous Cell Carcinoma and Adenocarcinoma for Radiotherapy-Treated Patients with Stage IIB-IVA Cervical Cancer.

Authors:  Fangjie Chen; Long Chen; Yu Zhang; Lei Shi; Hong'en Xu; Tao Song
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

5.  External Beam Therapy in a Four-Field Box Technique with Paclitaxel versus a Two-Field Technique with Cisplatin in Locally Advanced Carcinoma Cervix: A Phase II Monocentric Trial.

Authors:  Vijayakumar Narayanan; Bibek Bista; Samir Sharma
Journal:  ISRN Oncol       Date:  2012-12-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.